| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |